Should we expand the carbon ion footprint of prostate cancer?

Lancet Oncol. 2019 May;20(5):608-609. doi: 10.1016/S1470-2045(19)30094-4. Epub 2019 Mar 15.

Authors

Charles N Catton¹, David B Shultz²

Affiliations

¹ Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, ON M5G 1Z5, Canada. Electronic address: charles.catton@rmp.uhn.ca.
² Princess Margaret Cancer Centre and Department of Radiation Oncology, University of Toronto, Toronto, ON M5G 1Z5, Canada.

PMID: 30885459
DOI: 10.1016/S1470-2045(19)30094-4

No abstract available

Publication types

Comment

MeSH terms

Carbon
Cohort Studies
Heavy Ion Radiotherapy*
Humans
Male
Propensity Score
Prostatic Neoplasms*
Retrospective Studies

Substances

Carbon